The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1138
September 2, 2002
View Complete Issue         Table of Contents 2019 
Hormone Replacement Therapy
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Hormone Replacement Therapy
September 2, 2002 (Issue: 1138)
The results of a large randomized controlled trial of estrogen plus a progestin to prevent heart disease in postmenopausal women were recently reported (Writing Group for the Women's Health Initiative Investigators, JAMA 2002; 288:321).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Hormone Replacement Therapy
Article code: 1138c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.